The three‑month outperformance (+227.8% vs S&P +218.3%) stands out because it demonstrates that Penguin is generating roughly 4.4% additional return per month relative to the market, a signal of compelling near‑term catalysts such as new contract wins or margin expansion.
The long‑term edge is modest—only 8.2% above the S&P—meaning any sustained market correction or sector rotation could erode Penguin's premium; a 10% broad market decline would likely translate to an equivalent drop in its price, leaving little buffer for downside risk.
The 0.83 insider B/S ratio signals that insiders are marginally net sellers, translating to roughly $5M in sales versus $4.2M in purchases over the last quarter; this divergence could foreshadow concerns about upcoming operational challenges and warrants monitoring for potential earnings shortfalls.
The 16.9% YoY revenue jump stands out as the primary catalyst for earnings acceleration, pushing net margin above break‑even and delivering a positive free cash flow conversion of 7.3%, a rare feat in a sector where many peers still operate with negative cash flow.
The net margin of only 1.6% represents a $22.4 M profit on $1.4 B revenue; any increase in interest rates or unexpected tax liabilities could push the company back into net loss territory, eroding investor confidence and limiting cash return capacity.
The most significant profitability driver is the margin turnaround from -7.2% to +1.6%, which alone accounts for roughly 80% of the ROE improvement, signaling that operational restructuring and cost control measures are finally yielding earnings rather than just balance‑sheet adjustments.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | 3.6 | 1.6 | 0.85 | 2.71 | 7.6 | 6.5 | 1.3 |
| 2024 | -13.4 | -4.5 | 0.79 | 3.77 | 1.8 | 1.6 | -3.6 |
| 2023 | -84.3 | -13.0 | 0.96 | 6.77 | 0.9 | 0.8 | -12.5 |
| 2022 | 17.9 | 4.8 | 0.89 | 4.23 | 7.2 | 6.4 | 4.2 |
| 2021 | 6.9 | 2.0 | 0.78 | 4.33 | -2.1 | -2.1 | 1.6 |
| 2020 | -0.4 | -0.1 | 1.43 | 2.79 | 8.5 | 8.2 | -0.1 |
| 2019 | 18.8 | 4.2 | 1.72 | 2.57 | 19.6 | 19.1 | 7.3 |
| 2018 | 63.8 | 9.3 | 1.92 | 3.60 | 48.0 | 45.2 | 17.8 |
| 2017 | -9.5 | -1.0 | 1.59 | 5.83 | 25.2 | 22.4 | -1.6 |
| 2016 | 1613.6 | -3.7 | 1.17 | -370.78 | 3.0 | 2.7 | -4.4 |
| 2015 | -537.7 | -7.2 | 1.14 | 65.37 | -2.9 | -2.7 | -8.2 |
The 78‑day cash conversion cycle represents a $45 million working‑capital drag (based on average daily sales of ~$1.5 M), exposing the firm to funding risk if credit terms tighten or sales decline, which could erode the modest ROIC advantage.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 431 | 96 | 82 | 40 | 100 | 78 |
| 2024 | 460 | 67 | 78 | 52 | 80 | 65 |
| 2023 | 381 | 62 | 56 | 47 | 48 | 70 |
| 2022 | 411 | 96 | 93 | 44 | 106 | 82 |
| 2021 | 465 | 162 | 110 | 68 | 192 | 80 |
| 2020 | 256 | 66 | 72 | 26 | 91 | 47 |
| 2019 | 212 | 44 | 70 | 21 | 62 | 52 |
| 2018 | 191 | 81 | 69 | 16 | 82 | 68 |
| 2017 | 230 | 77 | 90 | 26 | 116 | 52 |
| 2016 | 313 | 88 | 99 | 39 | 169 | 18 |
| 2015 | 320 | 95 | 110 | 34 | 203 | 2 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $1617M | $1009M | $596M | $733M | $279M | $454M | $1064M | $474M |
| 2024 | $1475M | $1075M | $391M | $726M | $343M | $383M | $868M | $328M |
| 2023 | $1506M | $1277M | $222M | $857M | $491M | $366M | $907M | $426M |
| 2022 | $1572M | $1194M | $372M | $651M | $338M | $313M | $1152M | $516M |
| 2021 | $1345M | $1026M | $310M | $398M | $175M | $223M | $951M | $584M |
| 2020 | $787M | $505M | $282M | $222M | $71M | $151M | $557M | $282M |
| 2019 | $704M | $431M | $273M | $207M | $108M | $98M | $472M | $238M |
| 2018 | $673M | $486M | $187M | $212M | $180M | $31M | $522M | $296M |
| 2017 | $480M | $398M | $82M | $177M | $155M | $22M | $347M | $240M |
| 2016 | $459M | $460M | $-1M | $243M | $184M | $59M | $319M | $229M |
| 2015 | $565M | $556M | $9M | $247M | $179M | $68M | $411M | $313M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $109M | $25M | $-63M | $-9M | $100M | $-60M | $-8M |
| 2024 | $77M | $108M | $-210M | $-19M | $58M | $-21M | |
| 2023 | $104M | $-299M | $236M | $-39M | $65M | $-25M | |
| 2022 | $105M | $-39M | $74M | $-20M | $85M | $-57M | |
| 2021 | $153M | $-84M | $3M | $-17M | $137M | $-49M | |
| 2020 | $87M | $-32M | $13M | $-32M | $55M | $-1M | |
| 2019 | $170M | $-109M | $0M | $-33M | $136M | $-1M | |
| 2018 | $68M | $-68M | $8M | $-26M | $42M | $-2M | |
| 2017 | $-1M | $-18M | $-17M | $-19M | $-20M | ||
| 2016 | $15M | $-13M | $-11M | $-14M | $1M | $-0M | |
| 2015 | $41M | $-9M | $-33M | $-32M | $9M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net